No Data Available
Mylan Laboratories Share Price
BSE
Loading...
| Open | - |
| High | 210.00 |
| Low | 208.80 |
| Prev Close | 209.15 |
| Volume | 1,25,023 |
| VWAP(₹) | - |
Key Metrics
| PE Ratio(x) | - |
| EPS - TTM(₹) | - |
| MCap(₹ Cr.) | 3,272.95 |
| MCap Rank | - |
| PB Ratio(x) | - |
| Div Yield(%) | - |
| Face Value(₹) | - |
| 52W High(₹) | 227.00 |
| 52W Low(₹) | 48.00 |
| MCap/Sales | - |
| Beta(1 Month) | - |
| BV/Share(₹) | - |
Mylan Laboratories Ltd. share price insights
We don’t have any Insights for this stock currently.
Mylan Laboratories Ltd. Share Price Returns
| 1 Day | 0.0% |
| 1 Month | N.A. |
| 3 Months | N.A. |
| 1 Year | N.A. |
| 3 Years | N.A. |
| 5 Years | N.A. |
Mylan Laboratories Share Recommendations
No Recommendations details available for this stock.
Check out other stock recos.
Financials
No Data Available
No Data Available
No Data Available
No Data Available
Technicals
No Data Available
R1 - Pivot -
S1 - R2 - S2 - R3 - S3 - 5 Days 14 Days 28 Days - - -
Peer Comparison
- 1D
- 1W
- 1M
- 3M
- 6M
- 1Y
- 5Y
Choose from Peers
Choose from Stocks
- There’s no suggested peer for this stock.
Mutual Funds Ownership
No Data Available
Mylan Laboratories Ltd. Top Searches
Corporate Actions
Board Meeting
Quarterly Results
Jul 21, 2009
Board Meeting
Audited Results
Jun 16, 2009
General Meeting
To approve the amendments to the ESOP 2004, ESOP-1 2006, & ESOP-2 2009 Plans and the issuance of up to 1,839,345 equity shares of the Company to the ESOP Trust & to enter into Listing Agreement to bet the Company and the BSE & the NSE.
May 04, 2009
Announced on Meeting on Jul 21, 2009 Jul 29, 2009 Quarterly Results Jun 16, 2009 Jun 25, 2009 Audited Results Apr 02, 2009 Mar 27, 2009 Voluntary Delisting Offer Jan 29, 2009 Jan 28, 2009 Quarterly Results & Others Nov 03, 2008 Oct 29, 2008 Quarterly Results & Others Announced on Ex-Date Dividend% Jun 13, 2006 Sep 18, 2006 60% Jun 01, 2005 Aug 18, 2005 60% Oct 26, 2004 Dec 09, 2004 60% Jan 21, 2004 Jan 30, 2004 50% Jul 12, 2003 Aug 29, 2003 50% Announced on Ex-Date Oct 26, 2004 Jan 13, 2005 Bonus Ratio: 1 share(s) for every 1 shares held Announced on Ex-Date Oct 26, 2004 Jan 13, 2005 Split: Old FV10.0| New FV:2.0 No Data Available
Announced on Meeting on May 04, 2009 May 30, 2009 To approve the amendments to the ESOP 2004, ESOP-1 2006, & ESOP-2 2009 Plans and the issuance of up to 1,839,345 equity shares of the Company to the ESOP Trust & to enter into Listing Agreement to bet the Company and the BSE & the NSE. Mar 30, 2009 Apr 30, 2009 To initiate a voluntary delisting offer to the public shareholders of the Co. to delist the shares of the Company from the Bombay Stock Exchange Ltd and National Stock Exchange of India Ltd. & to appoint of Mr. S Srinivasan as CEO & M.D of the Co. Aug 14, 2008 Sep 15, 2008 Book closure from Sep 11, 2008 to Sep 15, 2008 May 24, 2007 Jul 16, 2007 Book closure from Jul 11, 2007 to Jul 16, 2007 Jul 31, 2006 Sep 25, 2006 60% Dividend
About Mylan Laboratories
Industry
Key Indices Listed On
-
Address
1-1-151/1, Sairam Towers, 4th Floor,Secunderabad, Andhra Pradesh - 500003
Executive Leadership
No Data Available
Auditors
No Data Available
Top Gainers
As on 12:11 PM | 19 Jun 2026Top Losers
As on 12:11 PM | 19 Jun 2026Trending in Markets
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.